In new trial, Zepbound bests Wegovy for weight loss 0 04.12.2024 22:50 United Press International (UPI.com) Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
